Free Trial

Clover Health Investments (NASDAQ:CLOV) Shares Down 3.1% - What's Next?

Clover Health Investments logo with Medical background

Shares of Clover Health Investments, Corp. (NASDAQ:CLOV - Get Free Report) dropped 3.1% during mid-day trading on Friday . The company traded as low as $4.00 and last traded at $4.05. Approximately 3,309,182 shares were traded during trading, a decline of 59% from the average daily volume of 8,076,871 shares. The stock had previously closed at $4.18.

Analyst Ratings Changes

Separately, UBS Group started coverage on Clover Health Investments in a report on Monday, October 7th. They set a "neutral" rating and a $4.00 price objective for the company.

View Our Latest Stock Report on Clover Health Investments

Clover Health Investments Price Performance

The firm has a market cap of $1.99 billion, a price-to-earnings ratio of -11.76 and a beta of 2.13. The firm has a fifty day simple moving average of $3.14 and a two-hundred day simple moving average of $1.82.

Clover Health Investments (NASDAQ:CLOV - Get Free Report) last issued its earnings results on Monday, August 5th. The company reported $0.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.04) by $0.05. Clover Health Investments had a negative return on equity of 36.55% and a negative net margin of 7.30%. The company had revenue of $356.26 million during the quarter, compared to analyst estimates of $338.70 million. During the same quarter last year, the business posted ($0.06) EPS. Equities analysts anticipate that Clover Health Investments, Corp. will post -0.13 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Clover Health Investments

A number of institutional investors have recently modified their holdings of the stock. Jupiter Asset Management Ltd. grew its holdings in Clover Health Investments by 18.1% during the first quarter. Jupiter Asset Management Ltd. now owns 4,525,079 shares of the company's stock worth $3,593,000 after acquiring an additional 692,878 shares during the period. XTX Topco Ltd acquired a new stake in shares of Clover Health Investments during the 2nd quarter worth approximately $932,000. AQR Capital Management LLC increased its holdings in shares of Clover Health Investments by 4.6% during the 2nd quarter. AQR Capital Management LLC now owns 729,706 shares of the company's stock valued at $898,000 after purchasing an additional 32,288 shares in the last quarter. Choreo LLC acquired a new position in shares of Clover Health Investments in the 2nd quarter valued at $344,000. Finally, Bayesian Capital Management LP purchased a new stake in Clover Health Investments during the first quarter worth $142,000. Hedge funds and other institutional investors own 19.77% of the company's stock.

About Clover Health Investments

(Get Free Report)

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.

Recommended Stories

Should you invest $1,000 in Clover Health Investments right now?

Before you consider Clover Health Investments, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clover Health Investments wasn't on the list.

While Clover Health Investments currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines